Celera Corporation: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[http://www.celera.com Celera Genomics] was established in May 1998 by the PE Corporation, now Applera Corporation, and J. [[Craig Venter]], Ph.D., a leading genomic scientist and founder of The Institute for Genomic Research ([http://www.tigr.org TIGR]). While at TIGR, Dr. Venter led the first successful effort to sequence an entire organism's genome, the H. influenzae bacterium. Deriving its name from the Latin word for swiftness, Celera was formed for the purpose of generating and commercializing genomic information to accelerate the understanding of biological processes. |
[http://www.celera.com Celera Genomics] was established in May 1998 by the PE Corporation, now Applera Corporation, and J. [[Craig Venter]], Ph.D., a leading genomic scientist and founder of The Institute for Genomic Research ([http://www.tigr.org TIGR]). While at TIGR, Dr. Venter led the first successful effort to sequence an entire organism's genome, the H. influenzae bacterium. Deriving its name from the Latin word for swiftness, Celera was formed for the purpose of generating and commercializing genomic information to accelerate the understanding of biological processes. |
||
Celera Genomics researchers were among the first to show the reliability of the [[whole genome shotgun]] strategy for sequencing both prokaryotic and eukaryotic genomes. This is in contrast with the public domain initialitevs, like these of the [[Human Genome Project]], that were based on a slower but safer [[clone by clone sequencing]] strategy. However, some researchers have pointed out doubts about the overall quality of Celera genome sequences. |
|||
(FIXME : insert references) |
|||
'''Genomes sequenced by Celera Genomics''' |
|||
Prokaryotes: |
|||
[[Haemophilus influenzae genome]] |
|||
Eukaryotes |
|||
[[Drosophila genome]] |
|||
[[Human genome]] |
|||
[[Mouse genome]] |
|||
Revision as of 14:17, 12 July 2003
Celera Genomics was established in May 1998 by the PE Corporation, now Applera Corporation, and J. Craig Venter, Ph.D., a leading genomic scientist and founder of The Institute for Genomic Research (TIGR). While at TIGR, Dr. Venter led the first successful effort to sequence an entire organism's genome, the H. influenzae bacterium. Deriving its name from the Latin word for swiftness, Celera was formed for the purpose of generating and commercializing genomic information to accelerate the understanding of biological processes.
Celera Genomics researchers were among the first to show the reliability of the whole genome shotgun strategy for sequencing both prokaryotic and eukaryotic genomes. This is in contrast with the public domain initialitevs, like these of the Human Genome Project, that were based on a slower but safer clone by clone sequencing strategy. However, some researchers have pointed out doubts about the overall quality of Celera genome sequences. (FIXME : insert references)
Genomes sequenced by Celera Genomics Prokaryotes: Haemophilus influenzae genome
Eukaryotes Drosophila genome Human genome Mouse genome